Last edition
News about "ORIC Pharmaceuticals "
ORIC and Cancer Research UK Advance CIP2A Cancer Therapy
ORIC Pharmaceuticals has announced agreement with Cancer Research UK to advance a potential first-in-class CIP2A-targeted therapy into clinical development.
ORIC Pharmaceuticals | 07/10/2026 | By News Bureau | 257
ORIC Pharmaceuticals Signs Clinical Supply Deal with Janssen Research and Development
Under the terms of the agreement, ORIC® will conduct and sponsor the trial and Johnson & Johnson will provide SC amivantamab.
ORIC Pharmaceuticals | 15/01/2025 | By Aishwarya | 472
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy